These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15619248)

  • 21. Toward the establishment of standardized in vitro tests for lipid-based formulations. 2. The effect of bile salt concentration and drug loading on the performance of type I, II, IIIA, IIIB, and IV formulations during in vitro digestion.
    Williams HD; Anby MU; Sassene P; Kleberg K; Bakala-N'Goma JC; Calderone M; Jannin V; Igonin A; Partheil A; Marchaud D; Jule E; Vertommen J; Maio M; Blundell R; Benameur H; Carrière F; Müllertz A; Pouton CW; Porter CJ
    Mol Pharm; 2012 Nov; 9(11):3286-300. PubMed ID: 23030411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastric pre-processing is an important determinant of the ability of medium-chain lipid solution formulations to enhance oral bioavailability in rats.
    Lee KW; Porter CJ; Boyd BJ
    J Pharm Sci; 2013 Nov; 102(11):3957-65. PubMed ID: 23983139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipid absorption triggers drug supersaturation at the intestinal unstirred water layer and promotes drug absorption from mixed micelles.
    Yeap YY; Trevaskis NL; Porter CJ
    Pharm Res; 2013 Dec; 30(12):3045-58. PubMed ID: 23793990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of oral absorption of cinnarizine--a highly supersaturating poorly soluble weak base with borderline permeability.
    Berlin M; Przyklenk KH; Richtberg A; Baumann W; Dressman JB
    Eur J Pharm Biopharm; 2014 Nov; 88(3):795-806. PubMed ID: 25195981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanostructured lipid carriers versus microemulsions for delivery of the poorly water-soluble drug luteolin.
    Liu Y; Wang L; Zhao Y; He M; Zhang X; Niu M; Feng N
    Int J Pharm; 2014 Dec; 476(1-2):169-77. PubMed ID: 25280882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Water-in-oil microemulsions containing medium-chain fatty acids/salts: formulation and intestinal absorption enhancement evaluation.
    Constantinides PP; Welzel G; Ellens H; Smith PL; Sturgis S; Yiv SH; Owen AB
    Pharm Res; 1996 Feb; 13(2):210-5. PubMed ID: 8932438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigating the correlation between in vivo absorption and in vitro release of fenofibrate from lipid matrix particles in biorelevant medium.
    Borkar N; Xia D; Holm R; Gan Y; Müllertz A; Yang M; Mu H
    Eur J Pharm Sci; 2014 Jan; 51():204-10. PubMed ID: 24134899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elucidating the Molecular Interactions Occurring during Drug Precipitation of Weak Bases from Lipid-Based Formulations: A Case Study with Cinnarizine and a Long Chain Self-Nanoemulsifying Drug Delivery System.
    Sassene PJ; Mosgaard MD; Löbmann K; Mu H; Larsen FH; Rades T; Müllertz A
    Mol Pharm; 2015 Nov; 12(11):4067-76. PubMed ID: 26393273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo evaluation of supersaturation/precipitation/re-dissolution behavior of cinnarizine, a lipophilic weak base, in the gastrointestinal tract: the key process of oral absorption.
    Tanaka Y; Kawakami A; Nanimatsu A; Horio M; Matsuoka J; Wada T; Kasaoka S; Yoshikawa H
    Eur J Pharm Sci; 2017 Jan; 96():464-471. PubMed ID: 27773836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Separation and characterization of the colloidal phases produced on digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected poorly water-soluble drugs.
    Kossena GA; Boyd BJ; Porter CJ; Charman WN
    J Pharm Sci; 2003 Mar; 92(3):634-48. PubMed ID: 12587125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fed and fasted state gastro-intestinal in vitro lipolysis: In vitro in vivo relations of a conventional tablet, a SNEDDS and a solidified SNEDDS.
    Christophersen PC; Christiansen ML; Holm R; Kristensen J; Jacobsen J; Abrahamsson B; Müllertz A
    Eur J Pharm Sci; 2014 Jun; 57():232-9. PubMed ID: 24056027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Examining the gastrointestinal transit of lipid-based liquid crystalline systems using whole-animal imaging.
    Pham AC; Nguyen TH; Nowell CJ; Graham B; Boyd BJ
    Drug Deliv Transl Res; 2015 Dec; 5(6):566-74. PubMed ID: 26328930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug solubilization behavior during in vitro digestion of suspension formulations of poorly water-soluble drugs in triglyceride lipids.
    Kaukonen AM; Boyd BJ; Charman WN; Porter CJ
    Pharm Res; 2004 Feb; 21(2):254-60. PubMed ID: 15032306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Revisiting dispersible milk-drug tablets as a solid lipid formulation in the context of digestion.
    Binte Abu Bakar SY; Salim M; Clulow AJ; Hawley A; Boyd BJ
    Int J Pharm; 2019 Jan; 554():179-189. PubMed ID: 30391337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of bile on the absorption of halofantrine from lipid-based formulations.
    Holm R; Tønsberg H; Jørgensen EB; Abedinpour P; Farsad S; Müllertz A
    Eur J Pharm Biopharm; 2012 Jun; 81(2):281-7. PubMed ID: 22465095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An in vitro digestion test that reflects rat intestinal conditions to probe the importance of formulation digestion vs first pass metabolism in Danazol bioavailability from lipid based formulations.
    Anby MU; Nguyen TH; Yeap YY; Feeney OM; Williams HD; Benameur H; Pouton CW; Porter CJ
    Mol Pharm; 2014 Nov; 11(11):4069-83. PubMed ID: 25265395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Encapsulation of poorly soluble basic drugs into enteric microparticles: a novel approach to enhance their oral bioavailability.
    Alhnan MA; Murdan S; Basit AW
    Int J Pharm; 2011 Sep; 416(1):55-60. PubMed ID: 21679756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a high-throughput in vitro intestinal lipolysis model for rapid screening of lipid-based drug delivery systems.
    Mosgaard MD; Sassene P; Mu H; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2015 Aug; 94():493-500. PubMed ID: 26159837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug solubilization behavior during in vitro digestion of simple triglyceride lipid solution formulations.
    Kaukonen AM; Boyd BJ; Porter CJ; Charman WN
    Pharm Res; 2004 Feb; 21(2):245-53. PubMed ID: 15032305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A possibility to predict the absorbability of poorly water-soluble drugs in humans based on rat intestinal permeability assessed by an in vitro chamber method.
    Watanabe E; Takahashi M; Hayashi M
    Eur J Pharm Biopharm; 2004 Nov; 58(3):659-65. PubMed ID: 15451542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.